Table 2.
1 h | 3 h | 24 h | 3 d | 7 d | |
---|---|---|---|---|---|
GPT (20–61 U/L)* | |||||
Fe3O4-PLGA | 65.50±2.64** | 65.50±3.32** | 45.50±3.11 | 47.50±12.4 | 44.70±14.86 |
Fe3O4-PLGA-cRGD | 64.50±2.65** | 65.75±4.92** | 44.74±2.06 | 47.75±13.37 | 47.25±11.53 |
GOT (39–111 U/L)* | |||||
Fe3O4-PLGA | 132.00±14.24** | 122.70±22.29** | 94.50±16.98 | 93.50±14.48 | 89.00±11.05 |
Fe3O4-PLGA-cRGD | 122.50±8.02** | 117.00±14.49** | 92.50±15.55 | 95.50±13.20 | 88.00±10.86 |
Total bilirubin (2–12 μmol/L)* | |||||
Fe3O4-PLGA | 4.50±1.29 | 3.50±1.29 | 4.50±1.29 | 4.25±1.50 | 4.50±1.29 |
Fe3O4-PLGA-cRGD | 3.50±0.58 | 4.25±1.25 | 4.00±1.41 | 4.25±1.50 | 3.75±0.96 |
Creatinine (4–57 μmol/L)* | |||||
Fe3O4-PLGA | 33.75±3.10 | 30.75±5.32 | 30.25±3.30 | 32.50±4.92 | 37.00±11.66 |
Fe3O4-PLGA-cRGD | 34.25±1.50 | 33.25±5.56 | 33.25±3.77 | 34.75±4.57 | 37.00±6.73 |
Urea (3.2–7.5 mmol/L)* | |||||
Fe3O4-PLGA | 5.75±0.96 | 6.42±0.90 | 4.50±1.15 | 5.45±1.62 | 6.92±0.46 |
Fe3O4-PLGA-cRGD | 6.00±0.60 | 5.98±0.67 | 5.55±0.86 | 5.85±1.14 | 6.43±0.72 |
Notes:
The remaining indicators are within normal ranges.
GPT and GOT increased slightly within 1 and 3 h, but returned to normal at the 24 h, 3 d, and 7 d time points after injection in the two groups.
Abbreviations: cRGD, cyclic Arg-Gly-Asp; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase; PLGA, poly(lactic-co-glycolic acid).